Pregnancy, epilepsy, and women's issues

CONTINUUM Lifelong Learning in Neurology

Volumn 19, Issue 3, 2013, Pages 697-714

  Pennell, Page B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ESTROGEN; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; FOLLITROPIN; GABAPENTIN; GONADORELIN; HARKOSERIDE; LAMOTRIGINE; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREGABALIN; PRIMIDONE; PROGESTERONE; RETIGABINE; RUFINAMIDE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADVERSE OUTCOME; ANTICONVULSANT THERAPY; BONE; CATAMENIAL EPILEPSY; CHILD DEVELOPMENT; CHILDBIRTH; CLIMACTERIUM; COMBINATION CHEMOTHERAPY; CONGENITAL MALFORMATION; DISEASE CONTROL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG WITHDRAWAL; EPILEPSY; ESTROGEN BLOOD LEVEL; FEMALE FERTILITY; FEMALE INFERTILITY; FETUS MALFORMATION; FETUS OUTCOME; FETUS RISK; FOLLITROPIN BLOOD LEVEL; GENERALIZED EPILEPSY; GINGIVA HYPERPLASIA; HORMONAL CONTRACEPTION; HUMAN; INFORMED CONSENT; KNOWLEDGE; LUTEINIZING HORMONE BLOOD LEVEL; MENOPAUSE; MONOTHERAPY; NERVE CELL DIFFERENTIATION; OBSERVATIONAL STUDY; ORAL CONTRACEPTION; OSTEOPOROSIS; OVARY POLYCYSTIC DISEASE; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRESCRIPTION; REPRODUCTION; REVIEW; SIDE EFFECT; TERATOGENICITY; WEIGHT GAIN; WOMEN'S HEALTH;

ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; WOMEN'S HEALTH;

EID: 84880159632     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000431383.14061.e6     Document Type: Review

References (45)

1. Harden CL, Pennell PB. Neuroendocrine considerations in the treatment of men and women with epilepsy. Lancet Neurol 2013;12(1):72-83.
2. Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997; 38(10):1082-1088. (Pubitemid 27424151)
3. Mattson RH, Cramer JA, Caldwell BV, Siconolfi BC. Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology 1984;34(9):1255-1258. (Pubitemid 14068605)
4. Herzog AG, Fowler KM, Smithson SD, et al. Progesterone vs placebo therapy for women with epilepsy: a randomized clinical trial. Neurology 2012;78(24):1959-1966.
5. Klein P, Serje A, Pezzullo JC. Premature ovarian failure in women with epilepsy. Epilepsia 2001;42(12):1584-1589. (Pubitemid 34020098)
6. Harden CL, Koppel BS, Herzog AG, et al. Seizure frequency is associated with age of menopause in women with epilepsy. Neurology 2003;61(4):451-455. (Pubitemid 37025359)
7. Harden CL, Pulver MC, Ravdin L, Jacobs AR. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 1999;40(10):1402-1407. (Pubitemid 29471340)
8. Harden CL, Herzog AG, Nikolov BG, et al. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study. Epilepsia 2006; 47(9):1447-1451. (Pubitemid 44393856)
9. Herzog AG. A relationship between particular reproductive endocrine disorders and the laterality of epileptiform discharges in women with epilepsy. Neurology 1993;43(10): 1907-1910. (Pubitemid 23318853)
10. Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91(2):456-488.
11. Pylva?nen V, Pakarinen A, Knip M, Isoja? rvi J . Characterization of insulin secretion in Valproate-treated patients with epilepsy. Epilepsia 2006;47(9):1460-1464. (Pubitemid 44393858)
12. Morrell MJ, Hayes FJ, Sluss PM, et al. Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine. Ann Neurol 2008;64(2):200-211.
13. Morrell MJ, Flynn KL, Done S, et al. Sexual dysfunction, sex steroid hormone abnormalities, and depression in women with epilepsy treated with antiepileptic drugs. Epilepsy Behav 2005;6(3):360-365. (Pubitemid 40468425)
14. Sukumaran SC, Sarma PS, Thomas SV. Polytherapy increases the risk of infertility in women with epilepsy. Neurology 2010; 75(15):1351-1355.
15. Dansky LV, Andermann E, Andermann F. Marriage and fertility in epileptic patients. Epilepsia 1980;21(3):261-271.
16. Artama M, Isojarvi JI, Raitanen J, et al. Birth rate among patients with epilepsy: a nationwide population-based cohort study in Finland. Am J Epidemiol 2004;159(11): 1057-1063.
17. Olafsson E, Hallgrimsson JT, Hauser WA, et al. Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia 1998;39(8):887-892. (Pubitemid 128721656)
18. Crawford P, Hudson S. Understanding the information needs of women with epilepsy at different lifestages: results of the 'Ideal World' survey. Seizure 2003;12(7): 502-507. (Pubitemid 37168640)
19. Centers for Disease Control and Prevention (CDC). U S. Medical Eligibility Criteria for Contraceptive Use, 2010. MMWR Recomm Rep 2010;59(RR-4):1-86.
20. Bounds W, Guillebaud J. Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs. J Fam Plann Reprod Health Care 2002; 28(2):78-80. (Pubitemid 34595936)
21. Harden CL, Meador KJ, Pennell PB, et al. Practice parameter update: management issues for women with epilepsyVfocus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73(2):133-141.
22. Harden CL, Pennell PB, Koppel BS, et al. Practice parameter update: management issues for women with epilepsyVfocus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009; 73(2):142-149.
23. Harden CL, Hopp J, Ting TY, et al. Practice parameter update: management issues for women with epilepsyVfocus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73(2):126-132.
24. Pennell PB. Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest? Epilepsia 2008;49(suppl 9): 43-55.
25. Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011; 10(7):609-617.
26. Tomson T, Battino D. Teratogenic effects of antiepileptic drugs. Lancet Neurol 2012; 11(9):803-813.
27. Hunt S, Russell A, Smithson WH, et al. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2008;71(4): 272-276.
28. Margulis AV, Mitchell AA, Gilboa SM, et al. Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol 2012;207(5):405.e1-405. e7.
29. Werler MM, Ahrens KA, Bosco JL, et al. Use of antiepileptic medications in pregnancy in relation to risks of birth defects. Ann Epidemiol 2011;21(11):842-850.
30. Pennell PB. The devil is in the details: not all AED-associated major congenital malformations are equal. Epilepsy Curr 2011;11(3):79-81.
31. Herná ndez-Díaz S, Smith CR, Shen A, et al. Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012;78(21): 1692-1699.
32. Holmes LB, Mittendorf R, Shen A, et al. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Arch Neurol 2011;68(10): 1275-1281.
33. Meador KJ. Neurodevelopmental effects of antiepileptic drugs. Curr Neurol Neurosci Rep 2002;2(4):373-378.
34. Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 2013;12(3):244-252.
35. Bromley RL, Mawer GE, Briggs M, et al. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs [published online ahead of print January 31, 2013]. J Neurol Neurosurg Psychiatry 2013. doi:10.1136/ jnnp-2012-304270.
36. Chen YH, Chiou HY, Lin HC, Lin HL. Affect of seizures during gestation on pregnancy outcomes in women with epilepsy. Arch Neurol 2009;66(8):979-984.
37. Pennell PB, Klein AM, Browning N, et al. Differential effects of antiepileptic drugs on neonatal outcomes. Epilepsy Behav 2012;24(4):449-456.
38. EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 2006;66(3):354-360.
39. Pennell PB, Hovinga CA. Antiepileptic drug therapy in pregnancy I: gestation-induced effects on AED pharmacokinetics. Int Rev Neurobiol 2008;83:227-240.
40. Pennell PB, Peng L, Newport DJ, et al. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology 2008;70(22 pt 2): 2130-2136.
41. Brodie MJ, Mintzer S, Pack AM, et al. Enzyme induction with antiepileptic drugs: cause for concern? Epilepsia 2013;54(1):11-27.
42. Carbone LD, Johnson KC, Robbins J, et al. Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women's health initiative (WHI). J Bone Miner Res 2010;25(4):873-881.
43. Pack AM, Morrell MJ, McMahon DJ, Shane E. Normal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugs. Epilepsy Behav 2011; 21(4):453-458.
44. Pack AM, Morrell MJ, Marcus R, et al. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol 2005;57(2):252-257. (Pubitemid 40179863)
45. Pack AM, Morrell MJ, Randall A, et al. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology 2008;70(18):1586-1593. (Pubitemid 351620313)